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It is now generally accepted that bete l - and betaa-
adreavceptors coexist in the hunts heart
. This was first
demonstrated by radioligand binding studies
(1
.2)
and sub-
sequently confirmed by functional in vitro studies that
showed that both beta
s- and betaradrenoceptms couple to
adenylate cyclase and mediate positive (notopk effects on
isolated ventricular and drial preparations (3) . Moreover,
various studies have shown that in humans the increase in
hart rate brought about by isoprenaine infusion is mediated
by both betas-
and bcta2adrenoceptoru to about the mine
degree (3,d)
. Conversely, to our knowledge only one group
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has demlmatrated a beta2-adtenoceptor-mediated positive
hatropit effect in humans in vivo (3 .b).
&Ia-adtanoccptor antagonists arc commonly used to
treat hypenemion,
win
pectoris and certain types of
arrhythmAs. Recent attempts have been made to use bem Y-
adre ioeeptor ausagoaAts such as metaprdol in the treat.
mum of chrunlo heart failure
(7)
. The rationale for this
unusual treatment is based an the observations that during
the natural craw of chronic heart hake, the sympathetic
aorvaus sydo is progressively 1allvated (8). One cosine-
quenee of the enhanced sympathetic activity is a downreg-
ulation of trident bus-adrenocepors. In the human heart
because the hem-adrenoceprorlade aylete cyciase/cyciic ad-
Maine monophospbate (cyclic AMP) system is the most
powerful physiologic mechanism to immediately increase
contractility or heart rate, or both(1-3), its depression any
therefore signdlmnty Contribute to disease progression.
Seal-adreooceptor alagonists may be useful under these
circumstances because they can prevent the deleterious
effects of enhanced noradre muse
(9).
In addition, they
upreplate beta-adrenoceptors (10,11) and hence restore
-.,rg7NM1-I M
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their previously attenuated funclioc Moreover. re-
cent sardies suggest that in patients with coronary artery
disease without apparent heart failure, kmg-icmt beta,-
adrenoceptor antagonist treatment can sensitize the right
atrhtl botaradremceplor mediating increases in farce of
contraction in vitro (11 .14) and in heart rate in vivo (15)
.
However, it is not known at present whether long-term
treatment with bola,-adrenoeeptor antagonists may affect
the functional responsiveness of beta,-adrenoceptors in the
human ventricular myocardium. This could be of clinical
importance because activation of ventricular beta,-
adrenoceptors may be an alternative therapeutic approach to
provide patients with chronic heart failure and long-tens
beta,-adrenooeptor antagonist treatment (and hence pos-
seming blocked beta,adrenrcepto s) immediate isotropic
support
To further characterize the functional role of beta,-
adtenoceptom in the human heart, in the present study we
i v stigated 1) the cardiac effects of the betaradecnaceptor
agoniet terbumiee in vitro in isolated human right atria) and
left ventricular preparations on adenylate cydase activity
and force of contraction and in vivo in seven he-mility , male
volunteers on beat rate and contractility (assessed by mea-
surement of systolic tree intervals), and 3) whether long-tern
treatment of the volunteers with the beta,-adrenoteptor-
selective antagonist bisoprolol would affect the in vivo
cardiac elects of terbutaline compared with those of iso-
Methods
Seven healthy male volunteers (mean I
`-SEMI age 263 -t
1 .5 years, lunge 22 to 31) partite in the study after
having given brimmed written consent
. The study was
approved by the institutional Ethics Committee . AB subjects
was drug fide and bad undergone physical examination to
exchrda asthma, chronic pulmonary disease . diabetes melli-
tus, hypertension, cardiac disease and other symptoms
pertaining
to the eerdiuvascula system; they were of aver-
age physical Shares, and cone exercised regularly
.
St* premed .
On entry Into the study volunteers re-
calved 10 mg of bisaprolol or placebo (at 8 AM) otnlly; 2 h
later the first agoniet infusion teal (isuprendine or tetbula-
line) was performed (day 1) . On the following day (day 2),
the second agonies was infused 2 h after the second dose of
10 mg
of blsoprolol or placebo. respectively . The sequence
of agonies administration was randomly allocated but kept
constant in cub volunteer throughout the study
. Thereafter,
the volunteers were
treated for 3 weeks with 10 mg of
bsoprolol or placebo (at 8 AM). On days 21 and 22, when the
volunteers wets std receiving treatment, the isoprsnaline or
teabnblioe infusion tests were repeated
. The last drug intake
was on day 22 at 8 Ass .
Between the two treatment regimens
a 4week drug-free period was required
. The isoprenaline
and tetbutalne infusions were always performed
in the
supine position after 2 b of rest &1 10 AM .
SCNAFERS ITT AL .
	
1225
HUMAN CARDIAC HrTA_ ADRRNOCEFrofS IN VIVO
In viva studs. Continuous systemic intravenous infu-
sions of isoprenafme and tcrbuWine were administered by
mesas of n
perfusions
potato (Braun)
. Incremental doses of
isopernaline and terhutaline were infused over a dose range
of 5 to 70 and 25 to 300 nglkg body weight per min .
respectively. Both ageoists were infused in three to six
incremental doses untl heart rate had increased by at least
25 bemslmin from baseline. The first two doses of each
agonist were kept constant (5 and 10 nglkg per min for
isoptetmline. 25 and 50 nglkg per min for terbutaline) .
Subsequent doses were tituated individually according to
individual responses until the target increase in heart rate of
25 heatslmin from baseline had been achieved . Isoprenaline
was infused for 10 min and terbutaline for 15 min at each
dose level.
Systolic and diastolic (Phase V) blood pressures were
measured by means
of an
automatic
: device (Tonoptist .
SpeideL and Kellerl. During the last 5 min of each dose step
of the agoniet infusions(ihat is, throughout minutes 5 to l0 of
the isuprenaline infusion and minutes 10 to 15 of the terbu-
taline infusion), blood pressure was measured at I-min
interve Is . The mean of these five recordings was chosen for
analysis of the dose-response curve . Measurements of sys-
tolic time intervals were obtained noninvasively, according
to staalard techniques (16,17), from simultaneous record-
ings or an electroeardiopraphde (ECG) lead, a phonocardio-
gram and a carotid pulse tracing at a high paper speed of
100 meals using a Siemens Mingograf Cardirex multichannel
ink jet recorder. At each dose level of the agonise infusions,
systolic time interval recordings were made during quiet
respiration after the last blood pressure tneasuremem . The
following intervals were measured: 1) RR interval (ms) of
the ECG, from which hwrt rate (heaLsimin) was calculated
.
2) Duration of the elatranechadieat systole (QS,-) (ms) from
the beginning of ulna Q wave of the FCG
to the first high
frequency vibratieas of the second heat sound
. 3) Duration
of the left ventricular ejection time (ms) from the rapid
upstroke to the trough of the incisuml notch of the carotid
pulse
tracing 4) Duration elf the pee-ejection period (ms) was
derived mathematically by subtracting left ventricular
ejec-
tion
time
from
Q52.
At each dose the man of 5 cardiac cycles was taken to
describe the dose-response relation
. Previous investigations
have demonstrated that averaging 5 cardiac cycles is suffi-
cient for an accurate determination of systolic time interval,
and increasing the number of boas analyzed to 20 cycles
does not significantly improve accuracy of measurements
(IS)
.
The QS 2 is highly dependent on changes
in heart rate
(16,17,19)
. Therefore, on an additional study day before
commencement of the main study, the relation between an
i-rease in heart rate induced by incremental intravenous
doses of atropine (dose range 0.1 to 2
.0 mg) and shortening
of QS2 was examined in each subject
. This was done to
evaluate the influence of an isolated increase in heart rate on
QS, (that is. an increase in heart rate that would not be
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Flgare 1. In vivo area-, methodology : analysis of individual dose-
response curves Dose..esponse curves for the percent increase in
best( rare (HR) (1r8) and percent shortening of pretjeetion period
(PEP) (r )O Induced by intravenous isoprenaline in one volunteer
after the first dose of placebo (Plat) and bisoprolol (Biro) (10 mg
orally). Ealctive dose (ED) values were derived from linear (heart
me) and hog How (pre-ejection period) regression analysis . The
eorerpmnding e&etive dose ratio (EDI,JED O ,,) describes the
negdmde of the rightward shift of the dose-eropense curve after
beta adeenoceptorblockade
. ED. -
dose of isopenaline (nejkg per
mini rcgtlited toahaten the paeilecdw pedodby 25% . ER, = dose
required to increase heart role by 50%
.
crease diastolic blood pressure by 25% (E0.5 ) and to shorten
pee-ejection period by 25% (ED25 ) and QS,c by 7 .5% (ED,..,)
were calculated and were expressed in nglkg per min
throughout. Typical experiments are shown in Figure I .
The magnitude of any antagonistic effect of an acute
selective beta,-adrenoceptor blockade with bisoprolol on
isopresaline- and terbuteline-induced changes in heart rate .
blood pressure and systolic time interval was described by
calculating the effective dose ratio (that is, the ratio of the
effective dose value after the first dose of bisoprolol LED m7e1
to that after the fast dose of placebo 1EDp m
l)
. Similarly . the
atective dose values after the first (day I) and last (day 21)
dose of bismprolol and placebo. respectively, were used to
calculate effective dose ratios describing the effects of
3 weeks of administration of placebo and bisoprolol .
Experimental data are expressed as mean value -- SEM
of a experiments. Effective dose values and ratios were
compared by paired
two-tailed
Student t lest, and p , 0.05
was considered significant .
In vitro sfedles. The pD2 values (that is . the negative
logarithm of the molar concentration of agoniat causing
half-maximal effect) were determined as previously de-
scribed by Van Rossum 1281
. Adenylate cyclase data were
analyzed by comps tersuppoted iterative nonlinear rcgrcs-
abn analysis using the lnPkR program (GmphPAD soft-
ware).
Data were fitted to sigmoidal curves; the bottom of
the curves was fixed at the experimentally determined basal
value (daesmined in the presence of 10 pmol/liter of GTP),
and the Hill slope was fixed at I to yield optimal estimates
for the maximal activation and the concentration of terbuta-
fine causing half-maximal activation (EC SO).
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The antagonist affinities of ICI 119,551(-log KB = pK a)
in the physiologic and adenylate cyclase experiments were
determined from the following equation :
pKa = Iog(CR - I) - log[ICI 118,551],
where CR = concentration ratio of the shift in the terbuta-
line-stimulated concentration-response curve, and LICI
118,5511 = concentration of Id 118.551 to produce this shift .
Drugs end. For infusions, isopccnalhte sulfate (Alcud .
rina) was purchased from Boetuinger lage)teim, terbutaline
sulfate (Bricanyt) from ASTRA Chemicals and atropine
sulfate (Atropinum Sultarieum) from Eifeghngo
. Bisoprolol
tablets (Concor) were kindly donated by E . Merck. (-)ISo-
prenaline bitartrate and terbutaline sulfate were purchased
from Sigma; COP 20712A (1-12-((3-carbamoyl-4-hydroxy)-
phcnoxy)ethylaminol-3.(4(1-methyl-4drifluoromethyl-2-
imidazolyl)phcaaucyl-2-propanol methanesulfonate) was a
gift of CIBA-GEIGY, and 10 119,551 hydrochloride
(erythro-(`-)-1-(7-methylndan-4y'
.oxy)-3-isopropylamino-
butan.2-oft was kindly donated by ICl Phar na . [Aipha-
5PIATP (specific activity 30 ClImmd) and 13H]eyelic AMP
(specific activity 44
.5 Cifmmol) were obtained from New
England Nuclear. All other chemicals were of the highest
purity grade commercially available .
Results
In vitro stad'les. Positive inotropic effects. In isolated
electrically driven human right atrial strips and left
ventric-
ular
trsbeculae, terbutaline (10-8
to l0
- + molfi(ter) caused
concentration-dependent increases in force of contraction
(Fig. 2): the pD2 values were 6.33 a 0.09 (n = 6, mris) and
5 .76 t 0.12 (n = 4, ventricles). When saturating concentra-
Fr)(nre 2. In vitro study . Effect of terbmaline on human right atlal
(A) and left vennicmar (B) force of contraction in the presence and
absence of the beta adrencecigo antagonist COP 20712 A p x
10' amilliter) and the beta0adrenoceptor antagonist ICI 118,551
(3
x
10
-s
mdltikr), eithergiven shone or in combination . Ordinate
positive iomropic aged of terbatattno as a percent of Ihv maximal
response to 100 pmdfiter
of isoprenatine
. Abrdaa
-
molar coo-
ceulralions of terhuta0ne. Volume mesa value ± SEM ; a = number
of experiments .
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Flea 3. In vitro study. Effect of tarbuh5ne en human tight atrhl
ll
)
and loft ventricular trials) adenylate cyelsae activity In the
presume and absence of the bearadrcaecepter aotlao. h t CUP
20712 A (3 x IF' 11m5fiar) or the beta,-admnoceplar anbleadat
10 118,551 (3 x IFa mctlliter) . Ordlm u -
adenylate
ylass
activity as a percent or tie lmsimul response to 100 pmoMlter e
isopmdim . Abscise = molar coooentorlons i terbotaine . Data
are am vain t SEK; a - number of experiments .
lions of terbttalne had induced maximal increases in farce
of contraction, addition of 10 to 100 pmoliliter of ieoprem-
line to the organ bath produced further increases in de-
veloped tension up to a maximal increase that was not
significantly different from that evoked by saturating can-
centratfms of calcium Ions. Thus, terbutaline caused maxi-
mal increases in force of contraction that in atria were 84
.9 *_
4
.7% (a - 6) and in ventricles only 49.2 ± 3 .7% (n = 4) of
JACC Vol. 23, No. 5
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those brought about by isoprenaline or calcium ions (Fig . 2).
In both tissues the beta2-adrenoceptor antagonist ICI
118,551 (3 x 10
-8
mollliter) shifted the concentration-
respotne curve for the positive inotropic effect of terbutaline
signi icantly to the right. whereas the beta s-adrenoccptor
antagonist COP 20712 A (3 x 10-7 moNl(ter) had no efect.
Accordingly, the combined application of ICI 118,551 and
CGP 20712 A did not increase the rightward shift induced by
ICI 118,551 alone (Fig. 2). The pKa
values for ICI 110,551
were 8.90±0.22(n=6)inrightatria and9 .04±0.31(a=4)
in left ventricles . respectively .
Adenylale cydase aetvfry .
In membranes from ho.
man right atria and left venricles, terbutaline (10'1 to
10-a molAite') induced coneeotreioo-deplmdeDi activation
of adenylate cychtse (Fig. 3), plying
pEC3
values of 6.04
0 .53 (a = 7, atria) and 5 .88 ± 0.72 (n = 3, ventricles);
maximal adenylate cyclase activation induced by terbummle
was 66.4 2 3.9% (atria) and 57.2 A 6.3% (ventricles) of
the evoked by 100 pmcNiter of isoprenaiine (p < 0.01) . In
both dashes ICI 118,551 (3 x 10-1 molNtea
shifted
the
ccncaaration-response curve for tmbutaline-induced adeny
.
late cyclase activation significantly to the right, yielding pKB
values of 9 .11 ± 0.19 (a = 7, atria) and 8.92 t 0.33 (n = 3,
left ventricles) . Conversely, COP 20712 A (3 x 10 -7 mold
liter) had Do effect (Fig. 3) .
bdveeadis. Two hours after the first adnmlniotratioa of
10 mg of bisaprolol, plasma levels were reached that care-
sponded to 75.7 t 3
.3% baa
nahdrenoceptor occupation,
whereas bea2adrenoceptar occupancy was <5%, the is,
below the detection limit of the method used (26)
.
After
Table 1. In Vivo Study of the Effects of Acute Selective Beta,-Adrcmceptor Elockade as Isaeenalae- and Tenbo fine-lndueed
Clauses in lte mdynmic Variables
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rgae 4. In viva study. Individual effective dose values far 50%
mcteeae la heart rate (EOass) induced by iniraveneus isopreteline
Poll) and terbutaine lrl8is) after the first dose of
placebo (PLACI
and b)snprolol (13150) (10 asp orally) . Mean ED_ values t
OEM
arc iudAsted by error burs . 'p < OAS versus placebo. Mean
I tSEMI maximal percent changes than baseline in heart rate for
isaprenaline were 67.9 x 6.8 after placebo and 65 .2 s 5.7 after
bisnprdol
; those for krbmaline were 64 .7
t
10.9 after placebo and
682 ± 4A after biaprold .
3 weeks of continuous bisoprolol treatment, values were
Beady identical (beta,-edrenoceptor occupancy 73.3 t
3.9%, beta2.adrenotugor occupancy <5%) .
Effects
of rbe first dose ofbisaprofol on isoprenaline- an d
xrbamflne induced effects. Isaprenaline infusion dose de-
peedemly increased systolic blood pressure and heart rate .
decreased diastolic blood pressure and shortened pre-
gectioe period and QS2c. Bisoprolol shifted the dose-
response curves to all isopreaaline-induced effects signifi-
cantly to the right; accordingly, the corresponding effective
dose values for iseprenaline were significantly higher after
bisoprolol than after placebo (Table 1 . Fig. 4 to 6).
As described in Methods, tedntalime was infused in doses
that carried the same maxi ml percent increase In heart rate as
isoprenaline (Fig
. 4) . Under these conditions terbutaline
caused the sane Deaf percent decrease in diastolic blood
pressure as isopreealine, whereas in the absence of betel
adrnnceptor blockade, maximal ieermes in systolic blood
pressure and ebarteoing of pre-jeetiae period and QS2c
wean significantly, less than those brought about by inspired-
dine
(Fig. $ and 6)
. Bisoprdal increased the caraponding
effective dose values for terbutatine-enoked hentodynamio
offsets to a much lease exteo ; than isoprenaline, and the
rightward shift inbreed by bisoprolol reached statistical
significance only m the shortening of QS2c (Table 1, Fig. 4 to
6) . Accordingly, the ratio EDw , edEDer ,a (as am index of the
amornt of rightward shift induced by bisoprobp was sigeif-
icandy higher for aft isepretaline effects than for terbutaline,
with the exception of a decrease in diastolic blood pressure .
Frets of long-term bisoprodl therapy oa iroprenaline-
dad terbarafne-Indared
effects. As shown in Table 2 after
3 weeks of treatment, bisoprolol antagonized isopraaline
or tetbstaline infusion-induced effects to nearly the same
ex= as did the rums dose of biseprolol. Accordingly, after
3 weeks of bleoprolol therapy, nearly all effective dose
values (Table 2) were not significantly different from those
SCLAFERS ET AL.
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rtgure S. In vivo nedy . Individual effective dose values for 10%
increase in systolic blood pressure (ED~) (trop) and for 25%
decrees,, in diasldic blood pressure (EDD ,,,) (balnm) induced by
intravenous isoprenaloe (loft) and terbutaline (rW after the first
dose of placebo (PLAC) and bisoprolol (BISO) (10 sag orally) . Man
ED_ and ED, values
t
SEM, respectively. are indicated by
user• Was. 'p < 0.-35 vmos placebo. Mean (±SEM)
maximal
percestchanges Prom baseline in systolic blood pressurefor isopren-
sine were 24.8 ± 1 .3 after placebo and 22.0 ± 4.4 after bissiprokil ;
those for lerburaline were 17
.1 ± 1 .1 after placebo and 17
.5 ± 1
.5
after bisoprolol III < 0
.001, rnaxinal ieprenaline vs, maximal
terbataline) . Mom (±SEM) maximal percent changes from baseline
in diastolic bland pressure far iwpreiwlim were 33.8 t 4.0 after
plasebo and 38.7 3 52 after tisepmtd ; those for terbrmmuv were
36.5 ±:5 .7 after placebo and 329 *_ 4.5 after btmprolol.
after the first dose of bisoprolol
; the sane held true for
maximal
percent changes (data not shown) . Of all variables
assessed only two were significantly reduced after long-term
bisoprolol treatment : the ED Ia value for isoprenaline-
induced increases in systole blood pressure and the ED 7 , 5
value for terbmaliaa induced shortening of QS2c .
Dlactatfflm
In Isolated human m7aci ,dial preparations, teebalalne
merenea amreci le throe and activuem adenylete cyelaae by
mesas of bansatkenasepars
. In the present study we in-
vestigated in vitro and in vivo the elects of the beta2-
adrenoceptor agonist terbutalne on contractility In human
ban . In vitro terbutaline caused concentnuion-dependent
activation of humor right at ial and left ventricular adenylate
cyclase and increases in force of contraction in isolated
electrically driven human right atrial and left ventricular
preparations
. Both effects were mediated by beta 2-
adeenoceptor stimulation because they were antagonized
only by the highly selective beta5adrenoceptor antagonist
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Table 2
. In Viva Study
of the Effects
vv Long-Term Selective Bete
l
-Admroceptor Blockade on Iseprenmaline- and Terbutalino-Induced
Changes in Hemodynam6: Variables
rpaOASand10.1epe1105.ED„w,Versus EDea, . o-6:LvoneeabjxsitwasrotpmdbkmeekaWoanED
ea
valueberarseehmewetnoekarrnt
6OM40apnee rWio. Mean (tEEM) effective dose values and
-ti.
(i.e., EDe ,,, IEDa„d for uoprernline. and Htbelaaao-urdaced changes in head sate.
ayslok and duttoac hood preemie (BPI . prcikction period (PEP) ad ham role-cnneded elec(roslvchmiml systole IQS 2c) 2 h avert a Ant (day D ad list
(day 211duae u bi apsalal (l0 ugardly). E&cii .edase valnes arc
expressed
in tenor dng/kg pertain urouglmut. Mean effective dose ratios represent the nmt
of IheindivMW effectiredese Nips afeach sabjeot (which does nmegtnl the radoof the mean eatet(vedoenvdmsk o - 7tlnoughom
. ED, so.
ED_Im-
ad Bonn,, as m Table 1.
hardly be justified for ethical reasons in view of the potential
hazards associated with this invasive procedure . Measure-
ment of systolic time intervals is an established noninvasive
method Air the evaluation of systolic ventricular perfor
macro (16,17). Moreover. the duration of the pre-ejection
period, which does get require correction for heart rate
(19.35). and heart rote-independent changes in the duration
of the total electromechanical systole (QS2) are inversely
correhted to invasive variables of left ventricular contractil-
ity (36,37). Available evidence from animal and human
studies clearly suggests din the pee-ejeetion
period and
bean r ae-independent changes in QS2
react more sensi-
tively
to
changes In contractile state than to alterations of
loading conditions
. First, in intact dogs the pro-ejection
period was more sensitive to isoprenaline and was less
ilmlxeced by the effects of vol une loading than many other
invasive contractility indexes (36). Second, in a recent study
do Mey et al
. (39) demonstrated that in healthy volunteers,
lmnvenaus isoprenaane Induced a significant shortening in
pre-5/ecdon period and heart mtrawsncted QS 2 at doses as
low as 0.1
dig/min
without any concomitant significant
changes in either hear rate or echocardiographic variables
of preload and afedoad. Third, the heart rate-corrected QS 2
has been shown to be unimpaired by reductions in preload
(40) and ,Rained (41,42) induced by pharmacologic inter-
vemioog that do not directly affect cardiac contractility.
From these observations we therefore conclude that the
observed changes in QS2c in our study are more likely to
reflect changes in cardiac inotropy than alterations in loadinr
conditions.
Accordingly, the significant shortening of the pre-ejection
period and QS2c induced by terbutaline and isoprenaline are
consistent with a positive inotropic effect of either agent .
Bisoprolol, given in a beta !-adrenoceptor-selective dose
(see earlier), significantly antagonized the isopren cline ef-
fects on the pre-ejection period and QS2c, indicating that
they involve mainly beta,-adrenmceptor stimulation. Con-
vcrscly, bisoprolol had a much weaker antagonizing effect
on terbuta(ine-induced shortening of the systolic time iater-
vals that reached statistical significance only for QS 2 c (Table
I)
. This is in keeping with the view that terbutaline evokes Its
positive inouopie effect predominantly through activation of
beta2-adrenoceptors. However, a snna0 beml-ndrenoceptor
component appears to be included In the positive inoerupism
elicited by terbutaline . a s demonstrated by the small in-
crease in effective dose values for the pre-fiection period
and QS2c after bisoprolol administration (Table 1)
. This-
is most likely brought about by activation of cardiac pre-
synaptic beta,-adrenaxptors, thereby releasing nomdrena-
fine that acts selectively in the human heart at taeta,-
adrenoccptors (20,30).
The present find(ngsare therefore in close ngeentent with
recently published data by Levine and Leenen (6) who
demonstrated by the use of echocardiographic assessment of
the systolic blood pressure/end-systolic left ventricular vol-
ume ratio as an index of inotropy 'bat In healthy volunteers,
the positive inotropic effect brought about by terbutallac was
mainly mediated by bem_radrenoceptor stimulation but ad-
ditionally included a small beta,-adrenoceptor component .
In this context it should be noted that in the present
study, terbutaline caused maximal percent changes in the
pre-ejection period, QS2c and systolic blood pressure that
Isapreodine Tmbotaline
Day 1 Dey 21 Day 1
Day 21
Heart rate
33 .7 ± 3.7
313x2 .0 139.1_1&9 132.9 2 1&9
EDaearif!Down
1 .02 2 0.15 5199 ± 0.11
Systole EP
®ma
23.1 ± 59
1 22 .0±'-7-
103A±24
.7
97.3 ± 12 .8
>fle,JEDn~. 0
.64 ± 0
.13 1 .11 10.13
Diastolic BP
22.2 x 4A 21 .0 2 3 .3f 1311.2 2 14 .4 135.8! 169
EDne EDoo .
1 .19 2 0.160 0.99 2 6.m
PEP
m2„ 20.5 ± 2.0 19
.7
2.7 1362 ± 25.7 127.9'- 1&7
EDay.
11006w
1.01 x 0.15 1 .04 ± 0.15
Q5,c
ED,,,, 28.0 2 3.0 20.653.3t 166711&3 1269 ± 14.6•
EDo
vsJEDe.r
0,75 a 0.12 0.78111m
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were significantly lower than those brought about by iso-
psenaline ; conversely. maximal increments in heart rate and
decreases in diastolic blood pressure (as a rough estimate of
changes in afterload) were nearly identical for both agunists .
These results favor the idea (similar to the in vitro situation
[see earlier]) that in humans, In vivo stimulation of cardiac
betaradrenoceptors causes only submaximat positive ino-
tropic effects.
Lang-term bloeprobl treatment does mot ameet terhoWlea-
Induced rhngm t howl
tote
and sytt0c War Intervals in
halthy
"huskers.
The second goal of this study was to
determine whether long-term treatment with a beta,-
adrenoceptor antagonist would affect these terbutline
induced, betas-adrenoceptor-mediated positive chrono-
tropic and inotropic effects in vivo . Recent studies had
shown that in patients with coronary artery disease, long-
term treatment with bet,-adrenoceptor antagonists upregi-
lated right aerial beta,-adrenoceptor numbers (10,11) but
simultaneously sensitized bet,adrcoeceptor function
(11,14) . In these atria the positive isotropic effect of nora-
drenaline (which Is mediated solely in the human heart by
bet,adrenoceptor stimulation, 120,30J) was not changed,
whereas that mediated by adrenaline (which has virtually
identical affinity in the human heart at bet,- and beta2-
adrenocepton (21.301) or by the beta2-adrenoceptor agonises
procaterol and salbutamol was markedly enhanced . Subse-
quently, Hall et al . (I5) also demonstrated a (right aerial)
bet
5adrenoceptor-sensitizing effect of long-term beta,-
adrenoceptor antagonist treatment in vivo . In patients with
long-term atenolol therapy, the increase in hear rate In-
duced by intracoronary injections of the beta 2-adrenocepeor
agonist salbutamol was significantly enhanced compared
with that in Iron-atenolol-trated patients. In the present
study, however, niter 3 weeks of treatment, the highly
selective beta,adreaoceptor antagonist bisoprolol (43)
caused nearly the same effects on isoprenaline- and terbuta-
line-induced increases in heart rate in the volunteers as did
the first single done of bisoprolol . It caused nearly identical
rightward shifts of the dose-rcspa tee curve to iaoprenaline
(Table 2) and did not affect the dose-response curve for
terbuteline . Thus, even after 3 weeks
of treatment, beta2-
adrenocydor-mediated incenses in heart rate were not
reduced by bisoprolol . Conversely, bisoprolol did not sensi-
tize bet,-adrenoceptor-mediated increases in hear rate .
The discrepancy between the present tint and those of Hall
et al. (15) may be due to the fact that 1) Hall et al
. injected
salbutamol in the right coronary artery of their patients, thus
avoiding any
systemic
effects, whereas we Infused terbuta-
lne intravenously (to reflect the usual clinical setting) ;
2) Hall et al. studied the effects of salbulamal 28 to 36 Is after
withdrawal of atentlol, whereas we studied terbutaline d.
Wit 2 h after bisoprolol dosing (that is, at peak plasma
bisoprolol levels) ; 3) Hall et al. studied patients with coro-
nary artery disuse -50 to 55 years old, whereas we studied
healthy volunteers -25 years old. Possibly, beta2-
adrenoceptor sensitization becomes moo prominent during
the withdrawal Phase of the beta,-adrenoceptcr antagonist ;
this assumption will be investigated in a forthcoming study .
Similar to increases in heart rate, the data of the present
study did not reveal consistent effects of long-term biso-
prolol treatment on ttabutaliae-induced, beta2adreCrocep-
tor-mediated, positive isotropic effects . As shown in Table
2, the weak antegomstie effect of bisoprolol on terbutalne
induced shortenng of the pro-ejection period was nearly
identical after 3 weeks of treatment, whereas the effect on
shortening QS3c time was significantly attenuated after 3
weeks of treatment with bisoprolol . Thus, aecordingto these
data, long-term beta,-adremceptor antagonist treatment
may or may not sensitize beta2adrenoceptor-mediated pos-
itive iaohnpic effects in humus. Conversely, it should be
emphasized that the (alight) antagonistic effects of bisoprolol
on terbntallne Induced, bem=-adrcaoceptor-tnedlated posi-
tive loorropic affects were certinly, not enhanced after
long-term bet,adrenoceptor aotagadst treatment .
Gsdmioae. The present results curly
d
trnte that
in the human heart stimulation of beta5adrenoceptwa can
evoke positive inotrapic effects not only in vitro but also in
vivo. Whether long-tam treatment with beta,adrenocepbor
antagonists is capable of sensitizing these betsadrenocep-
ter effects Is not clear at present. However, in the present
study long-term treatment with bisoprolol did at lease not
reduce bet2adreuoceptor-mediated positive inotsapic eP
fects of terbutdiae. These data therefore could open the
possibWty of treating patients with chronic heart failure
receiving long-term beta,adrctme eptor antagonist therapy
alternatively to therapy with behrw4renoceptor a uniuts .
such as dobutamme, wish besa2adrenoceptor agodsts If
Immediate inotrople support Is needed. However, the c0d-
cal effecdveneu of such treatment t the falng human hart
(with impaired bet,-and beta 5-edrenoeeptor function (1-3J)
remains to be proved.
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